NHS Blood and Transplant – Ban lifted on use of UK plasma to manufacture life-saving albumin treatments
Leading scientists at the independent Commission on Human Medicines (CHM) have confirmed that albumin can now be safely derived from UK plasma donors. Until recently, the use of UK-donated plasma to manufacture plasma-derived medicinal products has been banned, as a safety precaution against the spread of Creutzfeldt Jakob Disease (vCJD).
In 2020, the ban on using UK-sourced plasma to manufacture immunoglobulins, another type of plasma-derived medicinal product, was lifted. The MHRA can now confirm that, following further review of the evidence, the CHM has also recommended lifting the ban on treating patients with UK albumin.
Published on the 26th of June 2023. Find out more by reading ghe entire news report here, Ban lifted on use of UK plasma to manufacture life-saving albumin treatments.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (20 février 2024). NHS Blood and Transplant – Ban lifted on use of UK plasma to manufacture life-saving albumin treatments. ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/vvcq





